Your browser doesn't support javascript.
loading
RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease.
Mandigo, Amy C; Yuan, Wei; Xu, Kexin; Gallagher, Peter; Pang, Angel; Guan, Yi Fang; Shafi, Ayesha A; Thangavel, Chellappagounder; Sheehan, Beshara; Bogdan, Denisa; Paschalis, Alec; McCann, Jennifer J; Laufer, Talya S; Gordon, Nicolas; Vasilevskaya, Irina A; Dylgjeri, Emanuela; Chand, Saswati N; Schiewer, Matthew J; Domingo-Domenech, Josep; Den, Robert B; Holst, Jeff; McCue, Peter A; de Bono, Johann S; McNair, Christopher; Knudsen, Karen E.
Afiliação
  • Mandigo AC; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yuan W; The Institute of Cancer Research, London, United Kingdom.
  • Xu K; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Gallagher P; The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Pang A; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Guan YF; School of Medical Sciences and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Shafi AA; School of Medical Sciences and Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.
  • Thangavel C; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Sheehan B; Departments of Urology, Medical Oncology and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Bogdan D; Department of Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Paschalis A; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McCann JJ; The Institute of Cancer Research, London, United Kingdom.
  • Laufer TS; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Gordon N; The Institute of Cancer Research, London, United Kingdom.
  • Vasilevskaya IA; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Dylgjeri E; The Institute of Cancer Research, London, United Kingdom.
  • Chand SN; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Schiewer MJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Domingo-Domenech J; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Den RB; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Holst J; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McCue PA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • de Bono JS; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McNair C; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Knudsen KE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Cancer Discov ; 11(9): 2334-2353, 2021 09.
Article em En | MEDLINE | ID: mdl-33879449
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Proteína do Retinoblastoma / Neoplasias da Retina / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinoblastoma / Proteína do Retinoblastoma / Neoplasias da Retina / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article